Cancer Pharmacology Services

WuXi Biology offers an integrated package of preclinical cancer pharmacology services for targeted oncology and immuno-oncology.  Our platform includes in vitro cell-free and cell-based assays, a comprehensive panel of in vivo tumor models, and multidisciplinary ex vivo PD analysis services.

We have pioneered the development of over 1,500 PDX models across 30 cancer types, encompassing both prevalent and rare indications for solid and hematological malignancies.  We also offer comprehensive biomarker discovery support, utilizing a broad range of advanced technologies for both single and multiplex assay platforms.

Cancer pharmacology services_Flyer

Download